Galectin Therapeutics Inc. (GALT) vs Century Therapeutics, Inc. (IPSC)

A side-by-side comparison of Galectin Therapeutics Inc. and Century Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GALT vs IPSC

growth of $100 · dividends reinvested · last 5y
GALT -0.5% (-0.1%/yr)IPSC -93.5% (-42.1%/yr)GALT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$99$6
GALT IPSC

GALT vs IPSC: by the numbers

  • •IPSC is the larger company ($245M vs $244M market cap).
  • •Both run net losses; GALT's is the smaller (0.00% vs -8.78% net margin).

Metrics side by side

Valuation

MetricGALTIPSC
P/B ratioN/A1.06

Profitability

MetricGALTIPSC
Gross margin0.00%88.00%
Operating margin0.00%-13.78%
Net margin0.00%-8.78%
ROEN/A-47.25%
ROIC-1718.59%-43.69%

Growth (annualized)

MetricGALTIPSC
Total return CAGR (5Y)0.60%-42.05%

Frequently asked

How have GALT and IPSC total returns compared?
Over the past 5 years, GALT delivered 0.60% and IPSC delivered -42.05% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.